Late-stage melanoma was once untreatable. Immunotherapy is changing that

Melanoma seems to have found its match in immunotherapy, a type of treatment designed to help the immune system fight cancer. Just a decade ago, only one-in-20 patients would live for five years after being diagnosed with late-stage melanoma, with most dying in months. But drugs designed to trigger the body’s immune system mean 52 percent of patients now live for at least five years, according to a new clinical trial.

Patients with melanoma, which is the fifth most common cancer in the UK, can be cured if the cancer is caught in its early stages, but as cancer spreads throughout the body, then survival plummets. With immunotherapy, however, researchers have found that tumors are reduced in size and stunted from growing any bigger.

Are these patients cured? Saying cured is always difficult in cancer, but five-year-survival is a hugely significant milestone. Some patients taking the drugs…
Continue Reading at The Optimist Daily…